Monitoring of the Inflammatory Response of Patients With Premature Rupture of Membranes With Bedside Tests
EFFARM
Monitoring of Women With Preterm Premature Rupture of Membranes (PPROM) Between 28 and 33 Weeks of Gestation With Repetitive Immunochromatographic Bedside Test to Detect Inflammatory Protein in Vaginal Secretions.
1 other identifier
observational
60
1 country
1
Brief Summary
Prematurity represents 8% of birth and it is one of the leading causes of infant complications. The preterm premature rupture of membranes (PPROM) represents one-third of preterm birth and the rupture of membranes increase the risk of fetal exposition to infection which could lead to neurological sequels. Classic management of women with PPROM before 32SA is based on the extension of the pregnancy with the risk of adding complications like a secondary infection. Moreover, different studies have shown that fetal infection could be one of the most important risk factor for subsequent neurological complications. However, it is difficult to know if it is better to extend the pregnancy to gain in maturity or to arrest the pregnancy to avoid the risk of intrauterine infection. The research objective is to suggest a new strategy to manage women with PPROM. With this new strategy, the investigators seek to extend pregnancy as much as possible but the investigators would like to give birth before the intrauterine infection. The investigators suggest detecting protein associate with neurological complications of preterm child in the amniotic liquid found in the vagina of the mother. A positive test will lead to the delivery of the newborn before its infection. The hypothesis is that it is possible to study changes in the inflammatory status of patients who presented an PPROM from repeated detection of interleukins in vaginal secretions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 14, 2009
CompletedFirst Posted
Study publicly available on registry
July 15, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedJanuary 16, 2013
January 1, 2013
1 year
July 14, 2009
January 15, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
comparison between the results of the bedside test and the ELISA tests performed in the laboratory
after rupture of membranes
Secondary Outcomes (1)
description of the inflammatory status following a rupture of membranes at term and during labor
after rupture of membranes
Study Arms (1)
Rupture of fetal membranes
women with rupture of fetal membranes before onset of labor
Eligibility Criteria
women hospitalized for premature rupture of membranes at the CHUS
You may qualify if:
- Women with a single fetus and hospitalized for a rupture of membranes at term or before term.
- The criteria for diagnosis of rupture of membranes is based on clinical and biochemical tests, including Fern test and Actim PROM test
You may not qualify if:
- Twin pregnancies, patients in labor, the presence of medical complications which exclude expectant management including abruptio placentae, preeclampsia or eclampsia and fetal death.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre hospitalier de l'Université de Sherbrooke
Sherbrooke, Quebec, J1H 5N4, Canada
Biospecimen
vaginal secretions
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Charles Pasquier, MD, PhD
Centre hospitalier de l'Université de Sherbrooke
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DR
Study Record Dates
First Submitted
July 14, 2009
First Posted
July 15, 2009
Study Start
September 1, 2008
Primary Completion
September 1, 2009
Study Completion
December 1, 2009
Last Updated
January 16, 2013
Record last verified: 2013-01